Literature DB >> 13651548

The role of Hageman factor in the initiation of blood coagulation.

R M HARDISTY, J MARGOLIS.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION

Mesh:

Substances:

Year:  1959        PMID: 13651548     DOI: 10.1111/j.1365-2141.1959.tb04026.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  [Problems of blood coagulation in extracorporeal circulation with the heart-lung machine].

Authors:  R GROSS; R HOLEMANS
Journal:  Klin Wochenschr       Date:  1961-02-15

2.  Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.

Authors:  O D RATNOFF; E W DAVIE; D L MALLETT
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

3.  Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.

Authors:  S G IATRIDIS; J H FERGUSON
Journal:  J Clin Invest       Date:  1962-06       Impact factor: 14.808

4.  The mode of action of Hageman factor in the release of plasma kinin.

Authors:  J MARGOLIS
Journal:  J Physiol       Date:  1960-05       Impact factor: 5.182

5.  A modified whole blood partial thromboplastin test for the assessment of heparinization.

Authors:  P K Ray; D Abbott
Journal:  Can Med Assoc J       Date:  1973-06-23       Impact factor: 8.262

Review 6.  Genetics of human blood coagulation.

Authors:  C B Kerr
Journal:  J Med Genet       Date:  1965-12       Impact factor: 6.318

7.  The contact phase of coagulation in the presence of heparin.

Authors:  A L BLOOM
Journal:  J Clin Pathol       Date:  1962-11       Impact factor: 3.411

8.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

9.  Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).

Authors:  D C Morrison; C G Cochrane
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.